OOIR: Observatory of International Research

Papers

(The TQCC of Archives of Pharmacal Research is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Recent paclitaxel formulation strategies: expanding the therapeutic index by addressing biopharmaceutical and toxicity limitations	270
Mouse models of nonalcoholic steatohepatitis and their application to new drug development	107
Evaluation of bone health and fracture risk in type 2 diabetes: a network meta-analysis of anti-diabetic treatments versus placebo	88
Continuous TNF-α exposure in mammary epithelial cells promotes cancer phenotype acquisition via EGFR/TNFR2 activation	88
Osteogenic effect of an adiponectin-derived short peptide that rebalances bone remodeling: a potential disease-modifying approach for postmenopausal osteoporosis therapy	80
Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities	66
Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin	63
Challenges and opportunities of developing small-molecule therapies for age-related macular degeneration	62
Correction to: The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer	61
Impact of binge drinking on alcoholic liver disease	58
Donepezil improves skeletal muscle insulin resistance in obese mice via the AMPK/FGF21-mediated suppression of inflammation and ferroptosis	49
Germacrane and humulane sesquiterpenes from the roots and rhizomes of Valeriana officinalis var. latifolia and their anti-inflammatory and anti-influenza virus activities	45
Myriocin suppresses tumor growth by modulating macrophage polarization and function through the PI3K/Akt/mTOR pathway	45
PBPK modeling of the antidepressant doxepin incorporating CYP2D6 genotype for precision pharmacotherapy	45
Retraction Note: Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats	44
Regulation of NOX/p38 MAPK/PPARα pathways and miR-155 expression by boswellic acids reduces hepatic injury in experimentally-induced alcoholic liver disease mouse model: novel mechanistic insight	43
Prenylated flavonoid fractions from Glycyrrhiza glabra alleviate insulin resistance in HepG2 cells by regulating the ERK/IRS-1 and PI3K/Akt signaling pathways	42
Antibody-drug conjugates in cancer therapy: innovations, challenges, and future directions	42
Isolation, structure elucidation, total synthesis, and biosynthesis of dermazolium A, an antibacterial imidazolium metabolite of a vaginal bacterium Dermabacter vaginalis	38
Minor structural changes, major functional impacts: posttranslational modifications and drug targets	36
The role and application of transcriptional repressors in cancer treatment	35
Recent advances on Pestalotiopsis genus: chemistry, biological activities, structure–activity relationship, and biosynthesis	34
Non-alcoholic fatty liver disease and liver secretome	33
A review on bacteria-derived antioxidant metabolites: their production, purification, characterization, potential applications, and limitations	32
Tirzepatide mitigates atherosclerosis progression and modulates oxLDL-mediated proatherogenic effects in macrophages: evidence for M1/M2 homeostasis restoration	31

Naringin promotes fat browning mediated by UCP1 activation via the AMPK signaling pathway in 3T3-L1 adipocytes	31
Effects of fluconazole on the pharmacokinetics of celecoxib and its carboxylic acid metabolite in different CYP2C9 genotypes	28
Tumor microenvironment regulation by reactive oxygen species-mediated inflammasome activation	27
Anti-osteoporosis effects of triterpenoids from the fruit of sea buckthorn (Hippophae rhamnoides) through the promotion of osteoblast differentiation in mesenchymal stem cells, C3H10T1/2	27
Salvianolic acid A enhances Treg accumulation via the RUNX1/CBFβ/FOXP3 axis as a neuroprotective immunomodulator in ischemic stroke	26
The inhibition of endothelial DLL4-NOTCH1 signaling by 2'-hydroxyflavanone enhances anti-PD-1 therapy in melanoma	26
Phytochemistry and pharmacology of plants in the genus Chaenomeles	26
Cell membrane chromatography relative competitive method for the accurate determination of relative KD values of drug-receptor interactions	26
Immunosenescence and age-related immune cells: causes of age-related diseases	25
Predictive biomarkers for molecularly targeted therapies and immunotherapies in breast cancer	24
Dapagliflozin attenuates myocardial remodeling in hypertension by activating the circadian rhythm signaling pathway	24
Pralsetinib: chemical and therapeutic development with FDA authorization for the management of RET fusion-positive non-small-cell lung cancers	24
Nanostructured branched Y-DNA promotes antitumor immunity through dual activation of cGAS/STING and TLR9	23
Potential effects of a human milk oligosaccharide 6′-sialyllactose on angiotensin II-induced aortic aneurysm via p90RSK/TGF-β/SMAD2 signaling pathway	23
Ischemic stroke neuroprotection revisited: translational barriers and a phase-resolved, biomarker-anchored framework	21
Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects	21
Cathepsin B maturation plays a critical role in leptin-induced hepatic cancer cell growth through activation of NLRP3 inflammasomes	21
Paeonia genus: a systematic review of active ingredients, pharmacological effects and mechanisms, and clinical applications for the treatment of cancer	20
Potential of natural products in inflammation: biological activities, structure–activity relationships, and mechanistic targets	20
Akt-activated GSK3β inhibitory peptide effectively blocks tau hyperphosphorylation	19
Advances and challenges of estrogen receptor-targeted agents in breast cancer	19
Antibacterial properties of natural products from marine fungi reported between 2012 and 2023: a review	19
Natural compounds targeting inflammatory signaling and cell adhesion molecules in ischemic acute kidney injury	19
New tricyclic systems as photosensitizers towards triple negative breast cancer cells	19
Biodegradable gelatin methacryloyl microneedles: a new paradigm in transdermal drug delivery	18
Selumetinib overcomes gefitinib primary and acquired resistance by regulating MIG6/STAT3 in NSCLC	18
Homoharringtonine inhibits growth and migration in non-small cell lung cancer via PDIA4-mediated modulation of autophagy and EMT	17
Cardiotoxicity linked to anticancer agents and cardioprotective strategy	16
Effects of CYP2D6 and CYP2C19 genetic polymorphisms and cigarette smoking on the pharmacokinetics of tolperisone	16
Advanced therapeutic strategies targeting microglia: beyond neuroinflammation	16
Scope and challenges of nanoparticle-based mRNA delivery in cancer treatment	15
Physiologically based pharmacokinetic (PBPK) modeling of pitavastatin in relation to SLCO1B1 genetic polymorphism	15
Mechanistic insights and emerging therapeutic strategies targeting endothelial dysfunction in cardiovascular diseases	15
Curcumin targets CXCL16-mediated podocyte injury and lipid accumulation in diabetic kidney disease treatment	15
Inhibition of autophagy with chloroquine dysregulates mitochondrial quality control and energetics in adipocytes	15
Physiologically based pharmacokinetic (PBPK) modeling of piroxicam with regard to CYP2C9 genetic polymorphism	15